Table 3.
Lymphocyte subsets in peripheral blood: cervical cancer versus precancerous lesion
| Cancer (n = 43) | Precancerous lesion (n = 13) | P value* | |
|---|---|---|---|
| Gran %CD45 | 3.05 ± 5.29 | 4.17 ± 6.17 | 0.522 |
| T %MNC | 57.41 ± 12.79 | 59.58 ± 9.54 | 0.575 |
| rdT %T | 7.30 ± 4.45 | 4.83 ± 2.22 | 0.067 |
| B %MNC | 6.05 ± 3.11 | 6.48 ± 2.48 | 0.644 |
| pDC % MNC | 0.25 ± 0.13 | 0.35 ± 0.16 | 0.022# |
| CD11c + % pDC | 7.62 ± 5.03 | 6.18 ± 1.97 | 0.386 |
| Baso % MNC | 0.98 ± 0.71 | 1.19 ± 0.60 | 0.334 |
| BDCA1+ mDC % MNC | 0.38 ± 0.18 | 0.65 ± 0.23 | < 0.001# |
| BDCA3+ mDC % MNC | 0.17 ± 0.04 | 0.03 ± 0.05 | 0.374 |
| Mono %MNC | 15.56 ± 9.24 | 17.62 ± 8.01 | 0.473 |
| CD14+ Mo % MNC | 14.63 ± 6.98 | 16.98 ± 7.00 | 0.359 |
| CD16+ Mo % MNC | 3.07 ± 2.19 | 2.52 ± 1.04 | 0.448 |
| CD16+ %Mono | 15.58 ± 7.86 | 13.36 ± 3.29 | 0.020# |
| NK %MNC | 16.11 ± 9.34 | 10.90 ± 4.91 | 0.060 |
| CD56hi NK % MNC | 0.33 ± 0.15 | 0.29 ± 0.19 | 0.508 |
| CD56lo NK % MNC | 17.26 ± 9.62 | 10.36 ± 5.33 | 0.037# |
| CD56hi %NK | 2.54 ± 2.05 | 3.93 ± 3.03 | 0.106 |
| MDSC % CD33hi | 1.85 ± 3.32 | 3.42 ± 7.74 | 0.547 |
| DR- %14 + APC | 0.51 ± 1.55 | 0.38 ± 0.95 | 0.800 |
| DR- %16 + APC | 0.88 ± 1.60 | 0.44 ± 0.75 | 0.404 |
*Independent t test
#P values with statistical significance were denoted